Bobby Sandhu’s Post

Non contacting and non destructive chemical analysis can only done by Agilent handheld RAMAN Spectrometer. Typically no sample preparation to be done. #Agilent #Ramanspectroscopy #pharmaceutical #spectroscopyapplications

Only 5 days left! Don't miss out on our webinar to simplify your Pharma & Biopharma workflows with innovative UV-Vis technology. Achieve accurate results, measure complex samples with ease, boost productivity, and ensure GMP compliance. Register now and be prepared for the future of UV-Vis analysis! https://bit.ly/3OPF6Df #agilentindia #spectroscopy #uvvis #cary3500 #webinar

You may know that Pharmadule is a world leader in the design, manufacture, and delivery of Modular Manufacturing Facilities for the Pharma & Biopharma sectors. But you might not know that our parent company, Morimatsu Life Sciences, is a world-class manufacturer of pharma and biopharma process equipment. From stand alone equipment to complete, modular process skids, Morimatsu offers European pharma manufacturers significant benefits over its competitors, especially in terms of lead time and competitive pricing. In an industry where speed to market can be the deciding factor in a drug product's success, these benefits can make all the difference. Let's meet and explore what Morimatsu can do for your business. #Pharmaceuticals #Biopharma #Manufacturing #Morimatsu

Pharma Professionals, learn about the latest hurdles and opportunities in our latest Pharma Manufacturing article by Accruent's Chief Product and Technology Officer Richard Leurig.

2023 marked another record-breaking year! The overall drug pipeline expanded by 7.2%, reaching a new high of almost 23,000 drugs in development. Discover more essential insights in the new Pharma R&D Annual Review 2024. Download the full report today. https://ow.ly/n7eP50RcwMe #PharmaRnD #AnnualReview #PharmaTrends

2023 marked another record-breaking year! The overall drug pipeline expanded by 7.2%, reaching a new high of almost 23,000 drugs in development. Discover more essential insights in the new Pharma R&D Annual Review 2024. Download the full report today. https://ow.ly/Xoj950RcwxW #PharmaRnD #AnnualReview #PharmaTrends

🌞 Summer is coming, and with it, challenges for pharmaceutical companies to maintain product integrity in the heat. Discover how to prepare your temperature mapping and ensure your products remain safe and effective. 👉 Read the full blog: https://buff.ly/4bLTK7e #Pharma #TemperatureMapping #QualityAssurance #SummerReady #LifeSciencesblog

Pharma Professionals, learn about the latest hurdles and opportunities in our latest Pharma Manufacturing article by Accruent's Chief Product and Technology Officer Richard Leurig.

Pharma companies seek ways to use real-world data across the drug development lifecycle, from clinical trials to commercialization. MMIT’s Lance Wolkenbrod weighs in on the latest market trends you need to know on our blog: https://ow.ly/zu4p50Q0n5x. #Pharma #RealWorldData #WhatPharmaWants

The 505(b)(2) pathway has played a pivotal role in reducing time and streamlining the approval process by allowing drug manufacturers to rely on existing clinical data or literature produced by other companies. Pharma companies have been extensively utilizing the 505(b)(2) pathway to enhance existing drug products based on key features such as dosing regimen, formulation, and route of administration.   Veeda Group has shown robust support for drug development via the 505(b)(2) pathway: -  Successfully completed 45 studies, including 14 complex studies -   Database of over 1,300 volunteers -   Proficiency in More Than 10 Therapy Areas -   Collaborated with 25+ Global Sponsors   To know more about our support in accelerating Complex Drug Development through the 505(b)(2) Pathway write to us at info@veedacr.com or visit us at www.veedacr.com Partners in creating a healthier tomorrow.   #Veeda #VeedaCR #505b2 #Complexstudies #DrugDevelopment #Veedagroup #ClinicalResearch